Browsing by Autor "Stephanie Moscoso"

Now showing 1 - 6 of 6

Depression in medical students: an approach to Brazilian student’s depression in Bolivia
(Routledge, 2020) Estrella Flores; Evelyn Alanoca; Selma Olivera; Sun Ah Chung; Stephanie Moscoso; Cristian Roca
Depressive disorder affects millions of people each year, particularly to medical students. Several universities (medical schools) in Bolivia contain many Brazilian students. However, depression disorders in those students had been poorly reported. We aim to describe depressive symptoms in medical students in Bolivia and compare those symptoms between Brazilian and domestic students. To achieve that result, we conducted a cross-sectional study using the Beck Depression Inventory and demographic questions through an online survey. This survey was prepared in Google forms and distributed to medical students of the principal universities in the region, through their professors. Five hundred and nine students voluntarily participated in the study where we found that 107 participants (21.02%) have depressive symptoms. Younger medical students had higher scores in the Beck Depression Inventory (p = 0.02), and Brazilian medical students in Bolivia had lower scores than locals (p = 0.02). Finally, there were no statistical differences between depression throughout the academic year in medical school (p = 0.07). This is the first report of depression in foreign students in Bolivia. We demonstrated that approximately one-fifth of medical students in Santa Cruz, Bolivia have depressive symptoms. However, foreign students have less of these symptoms than local students.
Labeling of Genetically Modified (GM) Foods in Peru: Current Dogma and Insights of the Regulatory and Legal Statutes
(Hindawi Publishing Corporation, 2022) Jaime Delgado-Zegarra; Aldo Álvarez-Risco; Carmen Cárdenas; Massiel Donoso; Stephanie Moscoso; Brenda Rojas Román; Shyla Del-Aguila-Arcentales; Neal M. Davies; Jaime A. Yáñez
The COVID-19 pandemic has affected and afflicted human lives and been a transformative catalyst leading to closure of many companies, disrupting mental health, and reducing access to food and exacerbating food insecurity. This presents an opportunity to reflect on and examine genetically modified (GM) foods and their effective legislative regulation for the benefit of consumers. This review presents a detailed analysis of GM foods' regulation in Peru and the analysis of certain specific cases that show the need for greater regulation of the industry.
Serie de casos: intervención de la fisioterapia en alteraciones endocrinas y disfunciones orgánicas mediante magnetoterapia
(Cayetano Heredia University, 2022) Jorge Mendoza; Stephanie Moscoso; Samantha Silveira; Lorena Paniagua; Jean Chaparro; Sun Ah Chung; Cristian Roca
La Fisioterapia, mediante la terapia magnética (magnetoterapia), tiene la capacidad de intervenir en el funcionamiento endocrino y disfunciones orgánicas, por este motivo, se considera a esta técnica como una potencial herramienta para generar y evidenciar resultados en tratamientos de alteraciones endocrinas y organicas, El presente estudio analiza 4 casos donde se utilizó la magnetoterapia como alternativa de elección para quistes de origen hormonal y otras alteraciones organicas, Se evidencia que el diagn6stico fisioterapeutico ha sido diferente del diagn6stico médico, sin embargo, el uso de la magnetoterapia ha resultado en cambios positivos en las alteraciones evidenciadas en los pacientes, En conclusi6n, la magnetoterapia tiene potencial como terapia alternativa para el tratamiento de alteraciones endocrinas y disfunciones orgánicas.
Temáticas de la producción científica de la revista cubana de farmacia indizada en scopus (1967-2020)
(Editorial Ciencias Médicas, 2021) Sun Ah Chung; Selma Olivera; Brenda Rojas Román; Evelyn Alanoca; Stephanie Moscoso; Bianca Limpias Terceros; Aldo Álvarez-Risco; Jaime A. Yáñez
Introduccion: La Revista Cubana de Farmacia cumplio este ano su quincuagesimo cuarto aniversario, durante el cual ha publicado con exito, hasta el 2020, mas de 1110 trabajos indizados en la base de datos bibliografica Scopus. Objetivo: Describir la produccion cientifica desde el punto de vista tematico de la Revista Cubana de Farmacia indizada en Scopus. Metodos: Se realizo un estudio cualitativo, a partir de la revision sistematica de la literatura cientifica publicada por la Revista Cubana de Farmacia , disponible en Scopus. Se agruparon las publicaciones por areas tematicas de acuerdo al criterio de los autores, sobre la base de las palabras clave presentadas en los resumenes y el tema central del articulo. Las areas tematicas definidas fueron ocho, con siete subtemas. Conclusiones: Desde 1967, la Revista Cubana de Farmacia se ha esforzado por promover el avance de la ciencia y la investigacion en su pais de origen, Cuba. La variedad de sus articulos resulta de gran valor para investigadores y estudiantes extranjeros. Los estudios presentados se han caracterizado por la diversidad de temas relacionados con la farmacologia, el uso de plantas medicinales cubanas con fines terapeuticos y la metodologia para una mejor elaboracion de farmacos y procedimientos de laboratorios.
Tratamiento de la COVID-19 en Perú y Bolivia y los riesgos de la automedicación
(LA Referencia, 2020) Brenda Rojas Román; Stephanie Moscoso; Sun Ah Chung; Bianca Limpias Terceros; Aldo Álvarez-Risco; Jaime A. Yáñez
Introduction: Various drugs are being used against the symptoms caused by COVID-19, without being approved for these purposes. Many of these drugs have small safety margin and very risky adverse effects on health, a reason why they require prescription and, above all, medical monitoring and follow-up. Unfortunately, there are many cases of self-medication in Peru and Bolivia that require prompt management. Objective: To carry out a systematic review of the scientific literature that presents evidence about the effectiveness and adverse reactions of the drugs currently used against COVID-19 in Peru and Bolivia. Methods: Qualitative research based on the systematic review of the scientific literature available in PubMed, as well as in the national regulations of Peru and Bolivia related to the etiology, epidemiology, symptoms, as well as treatments approved and discontinued by both countries since the exacerbation of the COVID-19 crisis and the completion of clinical studies to date. Conclusions: The drugs used in Peru and Bolivia for treating COVID-19 have side effects and possible risks to the health of people who unfortunately self-medicate. Greater control of these drugs is required to avoid their free acquisition, and to improve the national and regional strategy to evaluate the possible symptomatic treatments of COVID-19, taking into consideration the high probability of survival of the disease and the risk posed by using these drugs, which, in the future, could cause serious adverse effects on public health in the two countries.
Treatment of COVID-19 in peru and bolivia, and self-medication risks
(Peruvian University of Applied Sciences, 2020) Brenda Rojas Román; Stephanie Moscoso; Sun Ah Chung; Bianca Limpias Terceros; Aldo Álvarez-Risco; Jaime A. Yáñez
Introduction: Various drugs are being used against the symptoms caused by COVID-19, without being approved for these purposes. Many of these drugs have small safety margin and very risky adverse effects on health, a reason why they require prescription and, above all, medical monitoring and follow-up. Unfortunately, there are many cases of self-medication in Peru and Bolivia that require prompt management. Objective: To carry out a systematic review of the scientific literature that presents evidence about the effectiveness and adverse reactions of the drugs currently used against COVID-19 in Peru and Bolivia. Methods: Qualitative research based on the systematic review of the scientific literature available in PubMed, as well as in the national regulations of Peru and Bolivia related to the etiology, epidemiology, symptoms, as well as treatments approved and discontinued by both countries since the exacerbation of the COVID-19 crisis and the completion of clinical studies to date. Conclusions: The drugs used in Peru and Bolivia for treating COVID-19 have side effects and possible risks to the health of people who unfortunately self-medicate. Greater control of these drugs is required to avoid their free acquisition, and to improve the national and regional strategy to evaluate the possible symptomatic treatments of COVID-19, taking into consideration the high probability of survival of the disease and the risk posed by using these drugs, which, in the future, could cause serious adverse effects on public health in the two countries.